Articles written by NewMediaWire - Benzinga

HUMACYTE DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on January 17, 2025

NEW YORK - (NewMediaWire) - November 22, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Humacyte, Inc. ("Humacyte" or the "Company") (NASDAQ:HUMA) on behalf of

HUMA Deadline to Lead in Securities Fraud Lawsuit is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP

NEW YORK - (NewMediaWire) - November 21, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Humacyte, Inc. ("Humacyte" or the "Company") (NASDAQ:HUMA) on behalf of

Women Warriors: A Legacy in Martial Arts

Kayla Harrison was the first American to win Olympic Gold in Judo (NewMediaWire) - November 20, 2024 - Glendale, Calif. - Martial arts, once perceived as a male-dominated domain, has undergone a significant

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP

NEW YORK - (NewMediaWire) - November 20, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Humacyte, Inc. ("Humacyte" or the "Company") (NASDAQ:HUMA) on behalf of

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025

NEW YORK - (NewMediaWire) - November 19, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Humacyte, Inc. ("Humacyte" or the "Company") (NASDAQ:HUMA) on behalf of

NFL s Arizona Cardinals provide 12 schools with CPR resources to improve cardiac emergency outcomes

(NewMediaWire) - November 19, 2024 - PHOENIX The American Heart Association and the Arizona Cardinals gathered representatives from 12 local schools for cardiopulmonary resuscitation (CPR) and automated external

Lost in the Labyrinth of L.A.'s Quirky Museums

(NewMediaWire) - November 18, 2024 - Glendale - Los Angeles, a city of dreams and desires, is a canvas painted with the strokes of the eccentric. Beyond its sun-kissed beaches and star-studded boulevards, LA harbors a

In a small international trial, novel oral medication muvalaplin lowered Lp(a)

Research Highlights: The oral medication muvalaplin may safely lower high levels of lipoprotein(a), also known as Lp(a), an independent, inherited risk factor for cardiovascular disease. Muvalaplin is a small molecule

NFL s Colts bring CPR education to flag football to improve cardiac emergency outcomes

(NewMediaWire) - November 18, 2024 - INDIANAPOLIS The American Heart Association and the Indianapolis Colts this past weekend brought cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED)

NY AI medical company wins global health tech competition at Scientific Sessions 2024

(NewMediaWire) - November 18, 2024 - DALLAS While major advances are being made in prevention of cardiovascular disease and stroke, which affects nearly 50% of adults in the U.S.,[1] experts urge new solutions to put

Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care

Research Highlights: A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they

QTRX ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Quanterix Corp (QTRX) for Potential Securities Law Violations

NEW YORK - (NewMediaWire) - November 18, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Quanterix Corp ("Quanterix" or the "Company") (NASDAQ:QTRX).CLICK HERE TO RECEIVE

Nasal spray version of common diuretic has potential to help treat heart failure

Research Highlights: A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation) in

A common heart failure medication may help prevent heart damage related to chemotherapy

Research Highlights: A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared to placebo among high-risk cancer patients being treated with

Reconditioned pacemakers worked as well as new ones

Research Highlights: Pacemakers reconditioned with an FDA-approved protocol worked as well as new devices in a study of nearly 300 people in seven low- and middle-income countries. The study compared the function and

Email reminders improved flu shot rates in Denmark, notably among heart attack survivors

Research Highlights: An electronic message to "nudge" patients to get a flu vaccine highlighting the cardiovascular benefits of flu shots improved vaccination rates among more than two million adults in three clinical

Two-medication combo pill lowered blood pressure among adults in India

Research Highlights: A study of three pills that combined two types of blood-pressure-lowering medications into one pill found that all combinations worked equally well among adults in India. Results from the TOPSPIN

Spironolactone, a blood pressure medication, may help reduce risk of new heart failure

Research Highlights: The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not significantly impact the rate of death, new heart attack or stroke. More

Patients taking edoxoban after heart valve surgery had lower risk of stroke, blood clots

Research Highlights: Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and blood clot prevention in patients after heart valve replacement surgery

Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or death

Research Highlights: The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries involving bypass did not result in significant benefits at preventing